Your browser doesn't support javascript.
loading
Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols.
Jakovljevic, M; Gutzwiller, F S; Schwenkglenks, M; Milovanovic, O; Rancic, N; Varjacic, M; Stojadinovic, D; Dagovic, A; Matter-Walstra, K.
Affiliation
  • Jakovljevic M; The Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia and Montenegro.
  • Gutzwiller FS; University of Basel, Basel, Switzerland.
  • Schwenkglenks M; University of Basel, Basel, Switzerland.
  • Milovanovic O; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia and Montenegro.
  • Rancic N; Military Medical Academy University of Defence Belgrade, Belgrade, Serbia and Montenegro.
  • Varjacic M; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia and Montenegro.
  • Stojadinovic D; Urology Clinic, University Clinical Center Kragujevac, Kragujevac, Serbia and Montenegro.
  • Dagovic A; Oncology and Radiation Therapy Center, Clinical Center Kragujevac, Kragujevac, Serbia and Montenegro.
  • Matter-Walstra K; University of Basel, Basel, Switzerland.
Value Health ; 17(7): A629, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27202230
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Country of publication: